Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enteral Itopride vs IV Metoclopramide for Feeding Intolerance
NCT07031479Phase 4Not yet recruiting
- Sponsor
- Chulalongkorn University
- Start
- Jul 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of itopride in feeding intolerance, sponsored by Chulalongkorn University. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
itopride
03
Conditions
feeding intolerance
Beyond the preview
Go deeper on NCT07031479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07031479.